van Dongen GAMS, Beaino W, Windhorst AD, Zwezerijnen GJC, Oprea-Lager DE, Hendrikse NH, van Kuijk C, Boellaard R, Huisman MC, Vugts DJ. The role of 89Zr-immuno-PET in navigating and derisking the development of biopharmaceuticals. J Nucl Med. 2021;62(4):438–45. https://doi.org/10.2967/jnumed.119.239558.

Article  CAS  PubMed  Google Scholar 

Lammertsma AA, Hoekstra CJ, Giaccone G, Hoekstra OS. How should we analyse FDG PET studies for monitoring tumour response? Eur J Nucl Med Mol Imaging. 2006;33(Suppl 1):16–21. https://doi.org/10.1007/s00259-006-0131-5.

Article  PubMed  Google Scholar 

Miedema IHC, Huisman MC, Zwezerijnen GJC, Grempler R, Pitarch AP, Thiele A, Hesse R, Elgadi M, Peltzer A, Vugts DJ, van Dongen GAMS, de Gruijl TD, Menke-van der Houven van Oordt CW, Bahce I. 89Zr-immuno-PET using the anti-LAG-3 tracer [89Zr]Zr-BI 754111: demonstrating target specific binding in NSCLC and HNSCC. Eur J Nucl Med Mol Imaging. 2023;50(7):2068–80. https://doi.org/10.1007/s00259-023-06164-w.

Wijngaarden JE, Huisman MC, Jauw YWS, van Dongen GAMS, Greuter HNJM, Schuit RC, Cleveland M, Gootjes EC, Vugts DJ, Menke-van der Houven van Oordt CW, Boellaard R. Validation of simplified uptake measures against dynamic Patlak Ki for quantification of lesional 89Zr-Immuno-PET antibody uptake. Eur J Nucl Med Mol Imaging. 2023;50(7):1897–905. https://doi.org/10.1007/s00259-023-06151-1.

van den Hoff J, Lougovski A, Schramm G, Maus J, Oehme L, Petr J, Beuthien-Baumann B, Kotzerke J, Hofheinz F. Correction of scan time dependence of standard uptake values in oncological PET. EJNMMI Res. 2014;4(1):18. https://doi.org/10.1186/2191-219X-4-18.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gambhir SS, Schwaiger M, Huang SC, Krivokapich J, Schelbert HR, Nienaber CA, Phelps ME. Simple noninvasive quantification method for measuring myocardial glucose utilization in humans employing positron emission tomography and fluorine-18 deoxyglucose. J Nucl Med. 1989;30(3):359–66.

CAS  PubMed  Google Scholar 

de Geus-Oei LF, Visser EP, Krabbe PF, van Hoorn BA, Koenders EB, Willemsen AT, Pruim J, Corstens FH, Oyen WJ. Comparison of image-derived and arterial input functions for estimating the rate of glucose metabolism in therapy-monitoring 18F-FDG PET studies. J Nucl Med. 2006;47(6):945–9.

PubMed  Google Scholar 

van der Weerdt AP, Klein LJ, Boellaard R, Visser CA, Visser FC, Lammertsma AA. Image-derived input functions for determination of MRGlu in cardiac (18)F-FDG PET scans. J Nucl Med. 2001;42(11):1622–9.

PubMed  Google Scholar 

Mourik JE, Lubberink M, Schuitemaker A, Tolboom N, van Berckel BN, Lammertsma AA, Boellaard R. Image-derived input functions for PET brain studies. Eur J Nucl Med Mol Imaging. 2009;36(3):463–71. https://doi.org/10.1007/s00259-008-0986-8.

Article  PubMed  Google Scholar 

Soderlund AT, Chaal J, Tjio G, Totman JJ, Conti M, Townsend DW. Beyond 18F-FDG: characterization of PET/CT and PET/MR scanners for a comprehensive set of positron emitters of growing application–18F, 11C, 89Zr, 124I, 68Ga, and 90Y. J Nucl Med. 2015;56(8):1285–91. https://doi.org/10.2967/jnumed.115.156711.

Article  CAS  PubMed  Google Scholar 

Soret M, Bacharach SL, Buvat I. Partial-volume effect in PET tumor imaging. J Nucl Med. 2007;48(6):932–45. https://doi.org/10.2967/jnumed.106.035774.

Article  PubMed  Google Scholar 

Börjesson PK, Jauw YW, de Bree R, Roos JC, Castelijns JA, Leemans CR, van Dongen GA, Boellaard R. Radiation dosimetry of 89Zr-labeled chimeric monoclonal antibody U36 as used for immuno-PET in head and neck cancer patients. J Nucl Med. 2009;50(11):1828–36. https://doi.org/10.2967/jnumed.109.065862.

Article  PubMed  Google Scholar 

Jauw YWS, Heijtel DF, Zijlstra JM, Hoekstra OS, de Vet HCW, Vugts DJ, Verheul HM, Boellaard R, Zweegman S, van Dongen GAMS, der Houven van Oordt CWM, Lammertsma AA, Huisman MC. Noise-induced variability of immuno-PET with zirconium-89-labeled antibodies: an analysis based on count-reduced clinical images. Mol Imaging Biol. 2018;20(6):1025–34. https://doi.org/10.1007/s11307-018-1200-4.

Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1(8476):307–10.

Article  CAS  PubMed  Google Scholar 

Kaalep A, Sera T, Oyen W, Krause BJ, Chiti A, Liu Y, Boellaard R. EANM/EARL FDG-PET/CT accreditation—summary results from the first 200 accredited imaging systems. Eur J Nucl Med Mol Imaging. 2018;45(3):412–22. https://doi.org/10.1007/s00259-017-3853-7.

Article  CAS  PubMed  Google Scholar 

Rahmim A, Cheng JC, Blinder S, Camborde ML, Sossi V. Statistical dynamic image reconstruction in state-of-the-art high-resolution PET. Phys Med Biol. 2005;50(20):4887–912. https://doi.org/10.1088/0031-9155/50/20/010.

Article  PubMed  Google Scholar 

Tabernero J, Ciardiello F, Rivera F, Rodrigeuz-Braun E, Ramos FJ, Martinelli E, Vega-Villegas ME, Roselló S, Liebscher S, Kisker O, Macarulla T, Baselga J, Cervantes A. Cetuximab administered once every second week to patients with metastatic colorectal cancer: a two-part pharmacokinetic/pharmacodynamics phase I dose-escalation study. Ann Oncol. 2010;21(7):1537–45. https://doi.org/10.1093/annonc/mdp549.

Article  CAS  PubMed  Google Scholar 

Alvarez-Argote J, Dasanu CA. Durvalumab in cancer medicine: a comprehensive review. Expert Opin Biol Ther. 2019;19(9):927–35. https://doi.org/10.1080/14712598.2019.1635115.

Article  CAS  PubMed  Google Scholar 

Hindorf C, Glatting G, Chiesa C, Lindén O, Flux G;,EANM Dosimetry Committee. EANM Dosimetry Committee guidelines for bone marrow and whole-body dosimetry. Eur J Nucl Med Mol Imaging. 2010;37(6):1238–50. https://doi.org/10.1007/s00259-010-1422-4.

Makris NE, Boellaard R, van Lingen A, Lammertsma AA, van Dongen GA, Verheul HM, Menke CW, Huisman MC. PET/CT-derived whole-body and bone marrow dosimetry of 89Zr-cetuximab. J Nucl Med. 2015;56(2):249–54. https://doi.org/10.2967/jnumed.114.147819.

Article  CAS  PubMed  Google Scholar 

Frings V, Yaqub M, Hoyng LL, Golla SS, Windhorst AD, Schuit RC, Lammertsma AA, Hoekstra OS, Smit EF, Boellaard R, QuIC-ConCePT Consortium. Assessment of simplified methods to measure 18F-FLT uptake changes in EGFR-mutated non-small cell lung cancer patients undergoing EGFR tyrosine kinase inhibitor treatment. J Nucl Med. 2014;55(9):1417–23. https://doi.org/10.2967/jnumed.114.140913.

van Sluis J, Boellaard R, Dierckx RAJO, van Esch ELM, Croes DA, de Ruijter LK, van de Donk PP, de Vries EGE, Noordzij W, Brouwers AH. Optimisation of scan duration and image quality in oncological 89Zr immunoPET imaging using the Biograph Vision PET/CT. Eur J Nucl Med Mol Imaging. 2023;50(8):2258–70. https://doi.org/10.1007/s00259-023-06194-4.

Article  CAS  PubMed  PubMed Central  Google Scholar